DiLillo, Katarina M.
Norman, Katy C.
Freeman, Christine M.
Christenson, Stephanie A.
Alexis, Neil E.
Anderson, Wayne H.
Barjaktarevic, Igor Z.
Barr, R. Graham
Comellas, Alejandro P.
Bleecker, Eugene R.
Boucher, Richard C.
Couper, David J.
Criner, Gerard J.
Doerschuk, Claire M.
Wells, J. Michael
Han, MeiLan K.
Hoffman, Eric A.
Hansel, Nadia N.
Hastie, Annette T.
Kaner, Robert J.
Krishnan, Jerry A.
Labaki, Wassim W.
Martinez, Fernando J.
Meyers, Deborah A.
O’Neal, Wanda K.
Ortega, Victor E.
Paine, Robert III
Peters, Stephen P.
Woodruff, Prescott G.
Cooper, Christopher B.
Bowler, Russell P.
Curtis, Jeffrey L.
Arnold, Kelly B.
,
Article History
Received: 31 August 2022
Accepted: 24 March 2023
First Online: 22 May 2023
Competing interests
: KMD, KCN, CMF, SAC, NEA, NEA, WHA, IZB, RGB, APC, EB, RCB, CBC, DJC, GJC, CMD, JMW, EAH, NNH, ATH, RJK, JAK, DAM, WKO, VEO, RP, SPP, PGW, RPB, JLC, KBA have no competing interests to declare. WWL reports personal fees from Konica Minolta and Continuing Education Alliance. MKH reports personal fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Cipla, Chiesi, Novartis, Pulmonx, Teva, Verona, Merck, Mylan, Sanofi, DevPro, Aerogen, Polarian, Regeneron, United Therapeutics, UpToDate, Medscape and Integrity. She has received either in kind research support or funds paid to the institution from the NIH, Novartis, Sunovion, Nuvaira, Sanofi, Astrazeneca, Boehringer Ingelheim, Gala Therapeutics, Biodesix, the COPD Foundation and the American Lung Association. She has participated in Data Safety Monitoring Boards for Novartis and Medtronic with funds paid to the institution. She has received stock options from Meissa Vaccines. FJM. has received personal fees from Forest, Janssen, GlaxoSmithKline, Nycomed/Takeda, Amgen, AstraZeneca, Boehringer Ingelheim, Ikaria/ Bellerophon, Genentech, Novartis, Pearl, Pfizer, Roche, Sunovion, Theravance, Axon, CME Incite, California Society for Allergy and Immunology, Annenberg, Integritas, InThough, Miller Medical, National Association for Continuing Education, Paradigm, Peer Voice, UpToDate, Haymarket Communications, Western Society of Allergy and Immunology, Informa, Bioscale, Unity Biotechnology, ConCert, Lucid, Methodist Hospital, Prime, WebMD, Bayer, Ikaria, Kadmon, Vercyte, American Thoracic Society, Academic CME, Falco, Axon Communication, Johnson & Johnson, Clarion, Continuing Education, Potomac, Afferent, and Adept; and has collected nonfinancial support from Boehringer Ingelheim, Centocor, Gilead, and Biogen/Stromedix; and declares other interests with Mereo, Boehringering Ingelheim, and Centocor. All are outside of this project.